Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In idiopathic pulmonary fibrosis, the quantitation of disease severity using pulmonary function tests is often confounded by emphysema. We have identified the composite physiologic index (CPI) most closely reflecting the morphologic extent of pulmonary fibrosis. Consecutive patients with a clinical/computed tomography (CT) diagnosis of idiopathic pulmonary fibrosis (n = 212) were divided into group I (n = 106) and group II (n = 106). The CPI was derived in group I (by fitting pulmonary function tests against disease extent on CT) and was tested in Group II. The formula for the CPI was as follows: extent of disease on CT = 91.0 − (0.65 × percent predicted diffusing capacity for carbon monoxide [DLCO]) − (0.53 × percent predicted FVC) + (0.34 × percent predicted FEV1). In group II, the CPI correlated more strongly with disease extent on CT (r2 = 0.51) than the individual pulmonary function test (DLCO the highest value, r2 = 0.38). A subanalysis demonstrated that the better fit of the CPI was ascribable to a correction of the confounding effects of emphysema. Mortality was predicted more accurately by the CPI than by a pulmonary function test in all clinical subgroups, including a separate cohort of 36 patients with histologically proven usual interstitial pneumonia (CPI, p < 0.0005; FVC, p = 0.002; PO2, p = 0.002). In conclusion, a new CPI, derived against CT and validated using split sample testing, is a more accurate prognostic determinant in usual interstitial pneumonia than an individual pulmonary function test.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the Composite Physiologic Index (CPI) and the Gender-Age-Physiology (GAP) index have been most commonly applied for estimating the survival of patients with IPF [3–6].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
In the citing paper
“CPI quantifies pulmonary function impairment due to pulmonary fibrosis, which is then correlated with the extent of fibrosis in computed tomography while excluding emphysema [3].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
Citations
Cites
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Austin, J. H., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Remy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Self-citationHistopathologic Variability in Usual and Nonspecific Interstitial Pneumonias
FLAHERTY, K. R., TRAVIS, W. D., COLBY, T. V., TOEWS, G. B., KAZEROONI, E. A., GROSS, B. H., JAIN, A., STRAWDERMAN, R. L., FLINT, A., LYNCH, J. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103074 · Cited by 665
Self-citationIdeal Alveolar Air and the Analysis of Ventilation-Perfusion Relationships in the Lungs
Riley, R. L., & Cournand, A. (1949) · Journal of Applied Physiology · doi:10.1152/jappl.1949.1.12.825 · Cited by 563
Travis, W. D., Matsui, K., Moss, J., & Ferrans, V. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00003 · Cited by 530
NICHOLSON, A. G., COLBY, T. V., DUBOIS, R. M., HANSELL, D. M., & WELLS, A. U. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003049 · Cited by 489
Self-citationIdiopathic Pulmonary Fibrosis: Predicting Response to Therapy and Survival
GAY, S. E., KAZEROONI, E. A., TOEWS, G. B., LYNCH, J. P., GROSS, B. H., CASCADE, P. N., SPIZARNY, D. L., FLINT, A., ANTHONY SCHORK, M., WHYTE, R. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9703022 · Cited by 406
Determinants of survival in idiopathic pulmonary fibrosis.
Schwartz, D. A., Helmers, R. A., Galvin, J. R., Van Fossen, D. S., Frees, K. L., Dayton, C. S., Burmeister, L. F., & Hunninghake, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306044 · Cited by 340
Research works printed but not linked: 7
- 1995, Am J Respir Crit Care Med, 151, 1180
- 1997, Arthritis Rheum, 40, 1229
- 1983, Clin Respir Physiol, 19, 1
- 1994, Am J Respir Crit Care Med, 149, 450, 10.1164/ajrccm.149.2.8306044 · DOI · Paper page
- 1983, Am Rev Respir Diagn, 2, 43
- 1976, Chest, 69, 263
- 1995, Am J Respir Crit Care Med, 151, 1180
Cited by
Items 101–200 of 705
Salisbury, M. L., Xia, M., Zhou, Y., Murray, S., Tayob, N., Brown, K. K., Wells, A. U., Schmidt, S. L., Martínez, F. J., & Flaherty, K. R. (2015) · CHEST Journal · doi:10.1378/chest.15-0530 · Cited by 124
Self-citationAmbulatory oxygen in interstitial lung disease: Table 1–
Visca, D., Montgomery, A., Lauretis, A. D., Sestini, P., Soteriou, H., Maher, T. M., Wells, A. U., & Renzoni, E. A. (2011) · European Respiratory Journal · doi:10.1183/09031936.00190710 · Cited by 117
Self-citationWnt Coreceptor Lrp5 Is a Driver of Idiopathic Pulmonary Fibrosis
Lam, A. P., Herazo-Maya, J. D., Sennello, J. A., Flozak, A. S., Russell, S., Mutlu, G. M., Budinger, G. R. S., DasGupta, R., Varga, J., Kaminski, N., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0079oc · Cited by 112
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis
Cottin, V., Hansell, D. M., Sverzellati, N., Weycker, D., Antoniou, K. M., Atwood, M., Oster, G., Kirchgaessler, K.-U., Collard, H. R., & Wells, A. U. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2492oc · Cited by 110
Self-citationIdiopathic Pulmonary Fibrosis: CT and Risk of Death
Ley, B., Elicker, B. M., Hartman, T. E., Ryerson, C. J., Vittinghoff, E., Ryu, J. H., Lee, J. S., Jones, K. D., Richeldi, L., King, T. E., et al. (2014) · Radiology · doi:10.1148/radiol.14130216 · Cited by 120
on behalf of the IPF-PRO Registry investigators, Todd, J. L., Vinisko, R., Liu, Y., Neely, M. L., Overton, R., Flaherty, K. R., Noth, I., Newby, L. K., Lasky, J. A., et al. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1103-4 · Cited by 104
Noth, I., Zangan, S. M., Soares, R. V., Forsythe, A., Demchuk, C., Takahashi, S., Patel, S. B., Strek, M. E., Krishnan, J. A., Patti, M. G., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00099910 · Cited by 113
Ash, S. Y., Harmouche, R., Lassala, D., Villalba, J. A., Ostridge, K., Gunville, R., Come, C. E., Onieva, J. O., Ross, J. C., Hunninghake, G. M., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0527-8 · Cited by 113
Smoking and interstitial lung diseases
Margaritopoulos, G. A., Vasarmidi, E., Jacob, J., Wells, A. U., & Antoniou, K. M. (2015) · European Respiratory Review · doi:10.1183/16000617.0050-2015 · Cited by 115
Self-citationVuillard, C., de Chambrun, M. P., de Prost, N., Guérin, C., Schmidt, M., Dargent, A., Quenot, J., Préau, S., Ledoux, G., Neuville, M., et al. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0433-3 · Cited by 114
The Syndrome of Combined Pulmonary Fibrosis and Emphysema
Cottin, V., & Cordier, J.-F. (2009) · CHEST Journal · doi:10.1378/chest.09-0538 · Cited by 114
Lindell, K. O., Olshansky, E., Song, M.-K., Zullo, T. G., Gibson, K. F., Kaminski, N., & Hoffman, L. A. (2010) · Heart & Lung · doi:10.1016/j.hrtlng.2009.08.005 · Cited by 102
Outcomes After Hospitalization in Idiopathic Pulmonary Fibrosis
Brown, A. W., Fischer, C. P., Shlobin, O. A., Buhr, R. G., Ahmad, S., Weir, N. A., & Nathan, S. D. (2014) · CHEST Journal · doi:10.1378/chest.13-2424 · Cited by 109
Fernandez, B. A., Fox, G. A., Bhatia, R., Sala, E., Noble, B., Denic, N., Fernandez, D., Duguid, N., Dohey, A., Kamel, F., et al. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-64 · Cited by 108
“Each HRCT was scored at five levels using the Royal Brompton Hospital system [23] and was classified into one of four categories: “definitely affected with IPF”, “probably affected”, “possibly affected” (early disease), and “unaffected”.”
MethodJacob, J., Bartholmai, B. J., Rajagopalan, S., Brun, A. L., Egashira, R., Karwoski, R., Kokosi, M., Wells, A. U., & Hansell, D. M. (2016) · BMC Medicine · doi:10.1186/s12916-016-0739-7 · Cited by 93
“…volume in one second (FEV1), forced vital capacity (FVC), total lung capacity (TLC), transfer coefficient of the lung for carbon monoxide (Kco), single breath carbon monoxide diffusing capacity corrected for haemoglobin concentration (DLco), and the composite physiologic index (CPI) [26].”
BackgroundSelf-citationBuch, M. H., Denton, C. P., Fürst, D. E., Guillevin, L., Rubin, L. J., Wells, A. U., Matucci‐Cerinic, M., Riemekasten, G., Emery, P., Chadha‐Boreham, H., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054866 · Cited by 105
Self-citationon behalf of the IPF-PRO Registry investigators, Todd, J. L., Neely, M. L., Overton, R., Durham, K., Gulati, M., Huang, H., Roman, J., Newby, L. K., Flaherty, K. R., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1190-z · Cited by 93
Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment
Khalil, N. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1030055 · Cited by 98
“However, some people may have an elevated neutrophil count caused by a concomitant infection.3 Hypergammaglobulinemia is seen in some IPF patients;59,60 elevated rheumatoid factor and antinuclear antibody titres are seen in about 40% of patients with IPF.3,4,59,60”
BackgroundInfluentialSugino, K., Ishida, F., Kikuchi, N., Hirota, N., Sano, G., Sato, K., Isobe, K., Sakamoto, S., Takai, Y., & Homma, S. A. (2013) · Respirology · doi:10.1111/resp.12207 · Cited by 98
Evaluation and management of alveolitis and interstitial lung disease in scleroderma
Latsi, P. I., & Wells, A. U. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200311000-00011 · Cited by 103
Self-citationWu, N., Xue, C., Yu, S., & Ye, Q. (2019) · Respirology · doi:10.1111/resp.13744 · Cited by 97
Wuyts, W. A., Wijsenbeek, M., Bondue, B., Bouros, D., Bresser, P., Robalo Cordeiro, C., Hilberg, O., Magnusson, J., Manali, E. D., Morais, A., et al. (2020) · Respiration · doi:10.1159/000504763 · Cited by 96
Chronic pulmonary aspergillosis complicating sarcoidosis
Uzunhan, Y., Nunès, H., Jeny, F., Lacroix, M., Brun, S., Brillet, P., Martinod, E., Carette, M., Bouvry, D., Charlier, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02396-2016 · Cited by 98
Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial
the Ifigenia study group*, Behr, J., Demedts, M., Buhl, R., Costabel, U., Dekhuijzen, R. P., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., et al. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-101 · Cited by 94
“We also calculated and analysed the Composite Physiological Index (CPI) [10].”
BackgroundMethodInfluentialSelf-citationZhang, L., Zhang, C., Dong, F., Song, Q. X., Chi, F., Liu, L., Wang, Y., & Che, C. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0300-7 · Cited by 95
“34 × percentage of predicted forced expiratory volume in 1 s [FEV1]) [15].”
BackgroundMura, M., Zompatori, M., Pacilli, A. M. G., Fasano, L., Schiavina, M., & Fabbri, M. (2006) · Respiratory Care · doi:10.4187/respcare.06510257 · Cited by 96
“In our experience, and in accordance with previous studies, 5,24 the extent of emphysema is usually more limited than the extent of fibrosis.”
MethodEvaluating disease severity in idiopathic pulmonary fibrosis
Robbie, H., Daccord, C., Chua, F., & Devaraj, A. (2017) · European Respiratory Review · doi:10.1183/16000617.0051-2017 · Cited by 93
Durheim, M. T., Collard, H. R., Roberts, R. S., Brown, K. K., Flaherty, K. R., King, T. E., Palmer, S. M., Raghu, G., Snyder, L. D., Anstrom, K. J., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00093-4 · Cited by 87
Recent advances in understanding idiopathic pulmonary fibrosis
Daccord, C., & Maher, T. M. (2016) · F1000Research · doi:10.12688/f1000research.8209.1 · Cited by 87
Pirfenidone improves survival in IPF: results from a real-life study
Margaritopoulos, G. A., Trachalaki, A., Wells, A. U., Vasarmidi, E., Bibaki, E., Papastratigakis, G., Detorakis, S., Tzanakis, N., & Antoniou, K. M. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0736-z · Cited by 87
Self-citationS2K-Leitlinie zur Diagnostik und Therapie der idiopathischen Lungenfibrose
Behr, J., Günther, A., Ammenwerth, W., Bittmann, I., Bonnet, R. B., Buhl, R., Eickelberg, O., Ewert, R., Gläser, S., Gottlieb, J., et al. (2013) · Pneumologie · doi:10.1055/s-0032-1326009 · Cited by 110
“Das Vorliegen einer pulmonalen Hypertonie (definiert als mittlerer Pulmonalis-druck>25mmHg in Ruhe) ist mit einem erhöhten Mortalitätsri-siko assoziiert [139,140,179].”
Connective tissue diseases, multimorbidity and the ageing lung
Spagnolo, P., Cordier, J.-F., & Cottin, V. (2016) · European Respiratory Journal · doi:10.1183/13993003.00829-2015 · Cited by 95
on behalf of the IPF-PRO™ Registry investigators, Snyder, L., Neely, M. L., Hellkamp, A. S., O’Brien, E., de Andrade, J., Conoscenti, C. S., Leonard, T., Bender, S., Gulati, M., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1043-9 · Cited by 85
Predictors of mortality in fibrosing pulmonary sarcoidosis
Jeny, F., Uzunhan, Y., Lacroix, M., Gille, T., Brillet, P., Nardi, A., Bouvry, D., Planès, C., Nunès, H., & Valeyre, D. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.105997 · Cited by 93
Adegunsoye, A., Kropski, J. A., Behr, J., Blackwell, T. S., Corte, T. J., Cottin, V., Glanville, A. R., Glassberg, M. K., Griese, M., Hunninghake, G. M., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0238so · Cited by 97
Doubková, M., Švancara, J., Svoboda, M., Šterclová, M., Bartoš, V., Plačková, M., Lacina, L., Žurková, M., Binková, I., Bittenglová, R., et al. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12700 · Cited by 87
“40–42 For instance, the Composite Physiologic Index (CPI), which includes FVC, FEV1, DLCO and fibrosis extension on HRCT scan, has been successfully tested at baseline and longitudinal studies.(42) However, the use of these composite systems is not widespread in routine clinical practice.”
BackgroundIsobe, K., Hata, Y., Sakamoto, S., Takai, Y., Shibuya, K., & Homma, S. A. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01666.x · Cited by 87
Jacob, J., Odink, A. E., Brun, A., Macaluso, C., Lauretis, A. D., Kokosi, M. A., Devaraj, A., Desai, S. R., Renzoni, E. A., & Wells, A. U. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.03.031 · Cited by 84
“The pulmonary function indices examined included forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), diffusing capacity for carbon monoxide (DLco), carbon monoxide transfer coefficient (Kco) and the composite physiological index (CPI) [16].”
BackgroundSelf-citationPark, H. J., Lee, S. M., Song, J. W., Lee, S. M., Oh, S. Y., Kim, N., & Seo, J. B. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.16.16054 · Cited by 88
Wang, K., Ju, Q., Cao, J., Tang, W., & Zhang, J. (2017) · Medicine · doi:10.1097/md.0000000000007083 · Cited by 81
Jacob, J., Bartholmai, B. J., Rajagopalan, S., Kokosi, M. A., Egashira, R., Brun, A., Nair, A., Walsh, S. L. F., Karwoski, R. A., & Wells, A. U. (2017) · European Radiology · doi:10.1007/s00330-017-5053-z · Cited by 87
Self-citationQiu, M., Jiang, J., Nian, X., Wang, Y., Yu, P., Song, J., & Zou, S. (2021) · Respiratory Research · doi:10.1186/s12931-021-01856-z · Cited by 86
Suzuki, H., Sekine, Y., Yoshida, S., Suzuki, M., Shibuya, K., Yonemori, Y., Hiroshima, K., Nakatani, Y., Mizuno, S., Takiguchi, Y., et al. (2011) · Surgery Today · doi:10.1007/s00595-010-4384-z · Cited by 84
Validation of the GAP Score in Korean Patients With Idiopathic Pulmonary Fibrosis
Kim, E. S., Choi, S. M., Lee, J., Park, Y. S., Lee, C., Yim, J., Yoo, C., Kim, Y. W., Han, S. K., & Lee, S. (2014) · CHEST Journal · doi:10.1378/chest.14-0453 · Cited by 84
Win, T., Screaton, N. J., Porter, J. C., Ganeshan, B., Maher, T. M., Fraioli, F., Endozo, R., Shortman, R. I., Hurrell, L., Holman, B. F., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3917-8 · Cited by 83
“These have been aimed mainly at IPF, although the original GAP (gender, age, physiology) model has been modified for use across all ILDs and shown to perform well [10, 22, 23].”
MethodSwigris, J. J., Kuschner, W. G., Kelsey, J. L., & Gould, M. K. (2005) · CHEST Journal · doi:10.1378/chest.127.1.275 · Cited by 86
Torrisi, S. E., Ley, B., Kreuter, M., Wijsenbeek, M., Vittinghoff, E., Collard, H. R., & Vancheri, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.01587-2018 · Cited by 79
Cottin, V. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-s1-s2 · Cited by 79
“A composite physiologic index may account for the extent of disease [15].”
BackgroundCombined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management
Hage, R., Gautschi, F., Steinack, C., & Schuurmans, M. M. (2021) · International Journal of COPD · doi:10.2147/copd.s286360 · Cited by 79
Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review
Alsomali, H., Palmer, E., Aujayeb, A., & Funston, W. (2023) · Pulmonary Therapy · doi:10.1007/s41030-023-00216-0 · Cited by 88
Acute respiratory distress syndrome mimickers lacking common risk factors of the Berlin definition
Gibelin, A., Parrot, A., Maître, B., Brun‐Buisson, C., Dessap, A. M., Fartoukh, M. S., & de Prost, N. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4064-y · Cited by 79
“, predominance of ground glass opacities) allow for predicting the response to a corticosteroid challenge [12, 24].”
BackgroundBergantini, L., Bianchi, F., Cameli, P., Mazzei, M. A., Fui, A., Sestini, P., Rottoli, P., & Bargagli, E. (2019) · Disease Markers · doi:10.1155/2019/8565423 · Cited by 83
Jo, H. E., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., et al. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0575-y · Cited by 77
“Physiologic measurements, such as FVC or diffusion capacity for carbon monoxide (DLco) have been commonly used [12, 13], as have composite measures of several physiologic values or demographic features [14, 15].”
BackgroundMethodSelf-citationA New Tool To Assess Sarcoidosis Severity
Wasfi, Y. S., Rose, C. S., Murphy, J. R., Silveira, L. J., Grutters, J. C., Inoue, Y., Judson, M. A., & Maier, L. A. (2006) · CHEST Journal · doi:10.1378/chest.129.5.1234 · Cited by 77
Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
Kakugawa, T., Sakamoto, N., Sato, S., Yura, H., Harada, T., Nakashima, S., Hara, A., Oda, K., Ishimoto, H., Yatera, K., et al. (2016) · Respiratory Research · doi:10.1186/s12931-016-0400-1 · Cited by 80
“Gender-AgePhysiology (GAP) stage and composite physiologic index (CPI) were calculated as described previously [12, 13].”
MethodDiagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis
Cano-Jiménez, E., Rodríguez, T. R. V., Martín-Robles, I., Castillo, D., García, J. J., de Miguel, E. B., Robles-Pérez, A., Galván, M. F., Roibas, C. M., Lara, S. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88734-2 · Cited by 80
Combined pulmonary fibrosis and emphysema in connective tissue disease
Cottin, V., & Cordier, J.-F. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328356803b · Cited by 81
“com physiologic index predicts mortality in isolated IPF and may account for disease severity [98], however there are uncertainties regarding its use in CPFE [9 && ].”
Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations
Jo, H. E., Randhawa, S., Corte, T. J., & Moodley, Y. P. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0366-1 · Cited by 79
Guler, S. A., Hur, S. A., Lear, S. A., Camp, P. G., & Ryerson, C. J. (2019) · Respiratory Research · doi:10.1186/s12931-019-1019-9 · Cited by 75
“A positive coefficient indicates an increase in the outcome variable per unit of the predictor variable (e.g., grip strength increases by an average of 0.115 kg for every 1% increase of DLCO %-predicted) Abbreviations: CI confidence interval, CPI composite physiologic index, DLCO diffusion capacity of the lung for car…”
MethodInfluentialRyerson, C. J., Tan, B., Fell, C. D., Manganas, H., Shapera, S., Mittoo, S., Sadatsafavi, M., To, T. M., Gershon, A. S., Fisher, J. H., et al. (2016) · Canadian Respiratory Journal · doi:10.1155/2016/3562923 · Cited by 79
“The Composite Physiologic Index will be used as an additional estimate of ILD severity, based on concurrent measurements of FVC, FEV 1 , and DLCO [30].”
MethodInfluentialA functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis
Huang, Y., Ma, S., Vij, R., Oldham, J. M., Herazo‐Maya, J. D., Broderick, S. M., Strek, M. E., White, S. R., Hogarth, D. K., Sandbo, N. K., et al. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0142-8 · Cited by 77
“[22].”
Nathan, S. D. (2005) · CHEST Journal · doi:10.1378/chest.127.3.1006 · Cited by 94
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Kärkkäinen, M., Kettunen, H.-P., Nurmi, H., Selander, T., Purokivi, M., & Kaarteenaho, R. (2017) · Respiratory Research · doi:10.1186/s12931-017-0642-6 · Cited by 72
Update on therapeutic management of idiopathic pulmonary fibrosis
Spagnolo, P., Τzouvelekis, Α., & Bonella, F. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s69716 · Cited by 78
“Besides GAP, which represents a true breakthrough in risk-stratification algorithms, other scoring systems have been proposed.(68) Wells et al reconciled indices of functional severity (FVC, DL CO , and forced expiratory volume in one second) and extent of disease (HRCT) to create a prognostic index (the composite phy…”
Lee, S. H., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., Park, C. S., Jeong, S. H., Park, Y. B., Lee, H. L., et al. (2016) · Respiratory Research · doi:10.1186/s12931-016-0454-0 · Cited by 68
“This might be explained by a difference in study design between the GAP model and CPI: GAP uses more clinical data in its model, such as age and gender, while CPI was created using only PFT results [12, 14].”
MethodResultBrillet, P., Cottin, V., Letoumelin, P., Landino, F., Brauner, W., Valeyre, D., Cordier, J.-F., & Nunès, H. (2009) · Journal de Radiologie · doi:10.1016/s0221-0363(09)70077-0 · Cited by 70
“Ainsi, dans la série de Wells et al. (4) des lésions d’emphysème étaient notées chez 36 % des patients ayant une fibrose pulmonaire idiopathique (FPI).”
BackgroundInfluentialElevated brain natriuretic peptide predicts mortality in interstitial lung disease
Corte, T. J., Wort, S. J., Gatzoulis, M. Α., Engel, R., Giannakoulas, G. A., Macdonald, P. M., & Wells, A. U. (2010) · European Respiratory Journal · doi:10.1183/09031936.00173509 · Cited by 68
“The composite physiologic index (CPI) was calculated according to the following formula [29]: CPI = 91 0.”
MethodSelf-citationNocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease
Troy, L. K., Young, I. H., Lau, E., WONG, K. K. H., Yee, B. J., Torzillo, P. J., & Corte, T. J. (2019) · Respirology · doi:10.1111/resp.13549 · Cited by 72
Gold, W. M., & Koth, L. L. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00025-7 · Cited by 87
Guler, S. A., Kwan, J. M., Leung, J. M., Khalil, N., Wilcox, P., & Ryerson, C. J. (2019) · European Respiratory Journal · doi:10.1183/13993003.00647-2019 · Cited by 68
Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis
Samara, K. D., Trachalaki, A., Tsitoura, E., Koutsopoulos, A. V., Lagoudaki, E. D., Lasithiotaki, I., Margaritopoulos, G. A., Pantelidis, P., Bibaki, E., Siafakas, N. M., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0692-9 · Cited by 70
Self-citationThe dual role of neutrophil elastase in lung destruction and repair
Lungarella, G., Cavarra, E., Lucattelli, M., & Martorana, P. A. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.12.008 · Cited by 67
Iwasawa, T., Asakura, A., Sakai, F., Kanauchi, T., Gotoh, T., Ogura, T., Yazawa, T., Nishimura, J., & Inoue, T. (2009) · Journal of Thoracic Imaging · doi:10.1097/rti.0b013e3181a6527d · Cited by 67
“Scoring of HRCT is usually semiquantitative with small interobserver variability when conducted by expert radiologists.(3,4,6,7) Although an automated segmentation using a computer system has been developed previously, to our knowledge, there is no commercially available system to evaluate the disease extent automatic…”
MethodSmoking‐related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung
Antoniou, K. M., Walsh, S. L. F., Hansell, D. M., Rubens, M. B., Marten, K., Tennant, R. C., Hansel, T. T., Desai, S. R., Siafakas, N. M., du Bois, R. M., et al. (2013) · Respirology · doi:10.1111/resp.12154 · Cited by 68
Self-citationKishaba, T., Shimaoka, Y., Fukuyama, H., Yoshida, K., Tanaka, M., Yamashiro, S., & Tamaki, H. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000988 · Cited by 68
Resting and exercise physiology in interstitial lung diseases
Lama, V. N., & Martínez, F. J. (2004) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2004.05.005 · Cited by 70
“A separate group has expanded these observations by generating a composite score that includes spirometric (FEV1 and FVC) and DLCO measurements [102].”
BackgroundWalsh, S. L. F., Wells, A. U., Sverzellati, N., Devaraj, A., von der Thüsen, J. H., Yousem, S. A., Colby, T. V., Nicholson, A. G., & Hansell, D. M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0479-0 · Cited by 73
“This index captures the severity of physiologic impairment due to interstitial lung disease while excluding the contribution from emphysema [24].”
BackgroundSelf-citationZisman, D. A., Keane, M. P., Belperio, J. A., Strieter, R. M., & Lynch, J. P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-940-0:003 · Cited by 75
“Similarly, investigators from the Brompton Hospital devised a composite physiological index (CPI) using radiographical and physiological information that predicted mortality more accurately than individual PFT in patients with IPF (115).”
Ryerson, C. J., O’Connor, D., Dunne, J. V., Schooley, F., Hague, C. J., Murphy, D. T., Leipsic, J. A., & Wilcox, P. (2015) · CHEST Journal · doi:10.1378/chest.15-0003 · Cited by 71
Cottin, V., Crestani, B., Cadranel, J. L., Cordier, J. F., Marchand-Adam, S., Prévot, G., Wallaert, B., Bergot, E., Camus, P., Dalphin, J., et al. (2017) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2017.07.017 · Cited by 69
Martínez, F. J. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200511-123jh · Cited by 68
Kaminski, N., Belperio, J. A., Bitterman, P. B., Chen, L., Chensue, S. W., Choi, A. M. K., Đačić, S., Dauber, J. H., du Bois, R. M., Enghild, J. J., et al. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0159su · Cited by 63
Review: Therapies for interstitial lung disease: past, present and future
Kim, R., & Meyer, K. C. (2008) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465808096948 · Cited by 66
“Although many objective parameters have been correlated with prognosis and disease progression for different fibrotic disorders [Meyer, 2007], particularly useful objective indicators of disease stability/progression for patients with IPF appear to be FVC, DLCO, and the 6-MWT [King et al. 2005; Flaherty et al. 2003; L…”
BackgroundNeutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis
Achaiah, A., Rathnapala, A., Pereira, A. Z., Bothwell, H., Dwivedi, K., Barker, R., Iotchkova, V., Benamore, R. E., Hoyles, R. K., & Ho, L. (2022) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001202 · Cited by 61
Hambly, N., Shimbori, C., & Kolb, M. (2015) · Respirology · doi:10.1111/resp.12569 · Cited by 55
Milne, K. M., Kwan, J. M., Guler, S. A., Winstone, T. A., Le, A., Khalil, N., Camp, P. G., Wilcox, P., & Ryerson, C. J. (2016) · Respirology · doi:10.1111/resp.12944 · Cited by 66
Cottin, V. (2013) · European Respiratory Review · doi:10.1183/09059180.00006812 · Cited by 69
Lee, S. M., Seo, J. B., Oh, S. Y., Kim, T. H., Song, J. W., Lee, S. M., & Kim, N. (2017) · European Radiology · doi:10.1007/s00330-017-5028-0 · Cited by 61
Stock, C. J. W., Hoyles, R. K., Daccord, C., Kokosi, M. A., Visca, D., Lauretis, A. D., Alfieri, V., Kouranos, V., Margaritopoulos, G. A., George, P. M., et al. (2020) · Respirology · doi:10.1111/resp.13988 · Cited by 59
Self-citationOh, A. S., Lynch, D. A., Swigris, J. J., Baraghoshi, D., Dyer, D. S., Hale, V. A., Koelsch, T. L., Marrocchio, C., Parker, K. N., Teague, S. D., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202301-084oc · Cited by 62
Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis
Sokai, A., Tanizawa, K., Handa, T., Kanatani, K., Kubo, T., Ikezoe, K., Nakatsuka, Y., Tokuda, S., Oga, T., Hirai, T., et al. (2017) · ERJ Open Research · doi:10.1183/23120541.00019-2016 · Cited by 54
Suzuki, Y., Aono, Y., Kono, M., Hasegawa, H., Yokomura, K., Naoi, H., Hozumi, H., Karayama, M., Furuhashi, K., Enomoto, N., et al. (2020) · Respirology · doi:10.1111/resp.13943 · Cited by 58
Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices
Jacob, J., Bartholmai, B. J., Rajagopalan, S., Egashira, R., Brun, A., Kokosi, M. A., Nair, A., Walsh, S. L. F., Karwoski, R. A., Nicholson, A. G., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.07.007 · Cited by 59
Self-citationon behalf of the SEPAR-IPF National Registry, Fernández‐Fabrellas, E., Molina‐Molina, M., Soriano, J. B., Portal, J. A. R., Ancochea, J., Valenzuela, C., & Xaubet, A. (2019) · Respiratory Research · doi:10.1186/s12931-019-1084-0 · Cited by 62
Dawes, T. J. W., McCabe, C., Dimopoulos, K., Stewart, I. D., Bax, S., Harries, C., Samaranayake, C. B., Kempny, A., Molyneaux, P. L., Seitler, S., et al. (2022) · Respirology · doi:10.1111/resp.14378 · Cited by 60
Self-citationJo, H. E., Troy, L. K., Keir, G. J., Chambers, D. C., Holland, A. E., Goh, N. S. L., WILSHER, M. L., de Boer, S., Moodley, Y. P., Grainge, C., et al. (2017) · Respirology · doi:10.1111/resp.13146 · Cited by 61
Self-citationElevated nocturnal desaturation index predicts mortality in interstitial lung disease.
Corte, T. J., Wort, S. J., Talbot, S., Macdonald, P. M., Hansel, D. M., Polkey, M. I., Renzoni, E. A., Maher, T. M., Nicholson, A. G., & Wells, A. U. (2012) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 55
Self-citationChamptiaux, N., Cottin, V., Chassagnon, G., Chaigne, B., Valeyre, D., Nunès, H., HACHULLA, E., Launay, D., Crestani, B., Cazalets, C., et al. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.10.011 · Cited by 55
Yoon, H., Kim, T. H., Seo, J. B., Lee, S. M., Lim, S., Lee, H. N., Kim, N., Han, M., Kim, D. S., & Song, J. W. (2018) · Respirology · doi:10.1111/resp.13387 · Cited by 54
Kennedy, B., Branagan, P., Moloney, F., Haroon, M., O’Connell, O. J., O’Connor, T. M., O'Regan, K. N., Harney, S., & Henry, M. T. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 55
Metadata
- Authors
- Wells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M.
- Affiliations
- Mayo Clinic (US)
- Department of Radiology and Department of Physiology Royal Brompton Hospital, Interstitial Lung Disease Unit; Department of Radiology, King's College Hospital, London, United Kingdom; and Department of Pathology, Mayo Clinic, Scottsdale, Arizona
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 167
- Issue
- 7
- Pages
- 962-969
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3022958008
- Cited by
- 686
- References
- 32
- Citations by year
- 2026: 18 · 2025: 31 · 2024: 28 · 2023: 39 · 2022: 37 · 2021: 48 · 2020: 42 · 2019: 40 · 2018: 40 · 2017: 52 · 2016: 47 · 2015: 42 · 2014: 27 · 2013: 38 · 2012: 22
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, usual interstitial pneumonia, composite physiologic index, pulmonary function tests, diffusing capacity for carbon monoxide, mortality prediction, prognostic score
- MeSH terms
- Aged, Biopsy, Carbon Monoxide, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Lung, Male, Middle Aged, Monitoring, Physiologic, Predictive Value of Tests, Prognosis, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Fibrosis, Statistics as Topic, Tomography, X-Ray Computed, Total Lung Capacity, Vital Capacity, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.